netFormulary

Darbepoetin Alfa Aranesp^®

First Choice

10, 15, 20, 30, 40, 50, 60, 80, 100, 150 & 300 microgram injections in prefilled syringes

20, 40, 60, 80, 100 & 300 microgram Sureclick® pens - approved for management of cancer treatment-induced anaemia in women receiving platinum-based chemotherapy for ovarian cancer

Monitoring: monitoring of erythropeoetin (darbepoetin) in adult patients can be undertaken by GPs under a shared care arrangement

Epoetin delta

Formulary

Epoetin theta

Formulary

Epoetin zeta

Formulary

Epoetin alfa Eprex^®

Formulary

Prefilled syringes (various strengths)
- Approved for management of cancer treatment-induced anaemia in
  women receiving platinum-based chemotherapy for ovarian cancer
- No longer regularly used in NUTH

Epoetin beta NeoRecormon^®

Formulary

Cartridges for use in RecopensPrefilled syringes
- Approved for management of cancer treatment-induced anaemia
  in women receiving platinum-based chemotherapy for ovarian cancer.
- No longer regularly used in NUTH.

Monitoring: monitoring of erythropeoetin (epoetin beta) in adult patients can be undertaken by GPs under a shared care arrangement

Methoxy Polyethylene Glycol-Epoetin Beta Mircera^®, Pegzerepoetin^® alfa

Formulary

30, 50, 100, 120, 150, 200 & 250 microgram in 0.3ml and 360 microgram in 0.6ml injections in prefilled syringes.
Approved for use as a longer-acting alternative to darbepoetin in a
small number of patients receiving peritoneal dialysis.